Payment overview · 2025
General Payments
$183.35
8 reported records · 5 companies
Healthcare provider profile · identity verified
Gary Paul Willers, DO
Allopathic & Osteopathic Physicians|Family Medicine · CUERO, TX · NPI 1255625422
Verified facts
What the public records show
CMS Open Payments records show Gary Paul Willers, DO received $183.35 in general payments during 2025 across 8 reported records.
Stryker Corporation accounted for 39.7% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 9 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Rexulti.
Otsuka America Pharmaceutical, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported REXULTI as an associated drug or biological on 160756 records involving 46288 distinct recipient NPIs. Public Medicare Part D data also shows 18 claims for Rexulti by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Stryker Corporation | Unresolved — no canonical attribution shown | $72.80 | 39.7% | 1 | 2025 |
| Bayer Healthcare Pharmaceuticals Inc. | Unresolved — no canonical attribution shown | $59.36 | 32.4% | 4 | 2025 |
| Merck Sharp & Dohme LLC | Unresolved — no canonical attribution shown | $19.67 | 10.7% | 1 | 2025 |
| Solventum Corporation | Unresolved — no canonical attribution shown | $16.12 | 8.8% | 1 | 2025 |
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $15.40 | 8.4% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $183.35 | 8 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| LIMFLOW SYSTEM Normalized: limflow system |
Device | Stryker Corporation | $72.80 | 1 | 2025 |
Source payment records
|
|||||
| Kerendia Normalized: kerendia |
Drug | Bayer Healthcare Pharmaceuticals Inc. | $59.36 | 4 | 2025 |
Source payment records
|
|||||
| CAPVAXIVE Normalized: capvaxive |
Biological | Merck Sharp & Dohme LLC | $19.67 | 1 | 2025 |
Source payment records
|
|||||
| ENFLONSIA Normalized: enflonsia |
Drug | Merck Sharp & Dohme LLC | $19.67 | 1 | 2025 |
Source payment records
|
|||||
| GARDASIL 9 Normalized: gardasil 9 |
Biological | Merck Sharp & Dohme LLC | $19.67 | 1 | 2025 |
Source payment records
|
|||||
| VAXNEUVANCE Normalized: vaxneuvance |
Biological | Merck Sharp & Dohme LLC | $19.67 | 1 | 2025 |
Source payment records
|
|||||
| ACTIV.A.C. Normalized: activ a c |
Device | Solventum Corporation | $16.12 | 1 | 2025 |
Source payment records
|
|||||
| PREVENA Normalized: prevena |
Device | Solventum Corporation | $16.12 | 1 | 2025 |
Source payment records
|
|||||
| REXULTI Normalized: rexulti |
Drug | Otsuka America Pharmaceutical, Inc. | $15.40 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| REXULTI rexulti |
2025 | Rexulti | 2024 | 18 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. Exact reporting entity; no affiliate inference |
2025 | REXULTI open payments reported associated product |
CMS Open Payments — General Payments 160756 supporting records · 46288 recipient NPIs · example record 1227267708 |
Rexulti · 2024 Exact normalized brand match · 1 Part D row |
18 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 804 | 143 |
| Levothyroxine Sodium | Levothyroxine Sodium | 629 | 105 |
| Gabapentin | Gabapentin | 596 | 100 |
| Amlodipine Besylate | Amlodipine Besylate | 585 | 115 |
| Furosemide | Furosemide | 564 | 95 |
| Pantoprazole Sodium | Pantoprazole Sodium | 560 | 77 |
| Eliquis | Apixaban | 555 | 46 |
| Potassium Chloride | Potassium Chloride | 535 | 74 |
| Trazodone Hcl | Trazodone Hcl | 533 | 69 |
| Donepezil Hcl | Donepezil Hcl | 486 | 46 |
| Lisinopril | Lisinopril | 465 | 85 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 446 | 67 |
| Sertraline Hcl | Sertraline Hcl | 373 | 45 |
| Losartan Potassium | Losartan Potassium | 361 | 85 |
| Metoprolol Tartrate | Metoprolol Tartrate | 352 | 66 |
| Tamsulosin Hcl | Tamsulosin Hcl | 350 | 54 |
| Metformin Hcl | Metformin Hcl | 281 | 58 |
| Alprazolam | Alprazolam | 266 | 45 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 265 | 62 |
| Memantine Hcl | Memantine Hcl | 251 | 28 |
| Metoprolol Succinate | Metoprolol Succinate | 251 | 46 |
| Mirtazapine | Mirtazapine | 234 | 32 |
| Escitalopram Oxalate | Escitalopram Oxalate | 216 | 33 |
| Hydrochlorothiazide | Hydrochlorothiazide | 206 | 38 |
| Divalproex Sodium | Divalproex Sodium | 205 | 25 |
| Myrbetriq | Mirabegron | 204 | 21 |
| Clopidogrel | Clopidogrel Bisulfate | 199 | 39 |
| Fluoxetine Hcl | Fluoxetine Hcl | 187 | 27 |
| Duloxetine Hcl | Duloxetine Hcl | 186 | 18 |
| Omeprazole | Omeprazole | 184 | 45 |
| Montelukast Sodium | Montelukast Sodium | 174 | 30 |
| Mounjaro | Tirzepatide | 173 | 22 |
| Carvedilol | Carvedilol | 172 | 31 |
| Tramadol Hcl | Tramadol Hcl | 172 | 33 |
| Xarelto | Rivaroxaban | 167 | 12 |
| Levetiracetam | Levetiracetam | 163 | 15 |
| Simvastatin | Simvastatin | 163 | 30 |
| Ozempic | Semaglutide | 161 | 26 |
| Allopurinol | Allopurinol | 156 | 29 |
| Metformin Hcl Er | Metformin Hcl | 137 | 26 |
| Jardiance | Empagliflozin | 135 | 23 |
| Alendronate Sodium | Alendronate Sodium | 134 | 18 |
| Pravastatin Sodium | Pravastatin Sodium | 131 | 23 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 128 | 20 |
| Buspirone Hcl | Buspirone Hcl | 125 | 17 |
| Ondansetron Hcl | Ondansetron Hcl | 125 | 46 |
| Pregabalin | Pregabalin | 116 | 16 |
| Meloxicam | Meloxicam | 115 | 27 |
| Finasteride | Finasteride | 108 | 16 |
| Baclofen | Baclofen | 103 | 20 |
| Prednisone | Prednisone | 102 | 24 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 98 | 12 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 97 | 22 |
| Latanoprost | Latanoprost | 95 | 14 |
| Amiodarone Hcl | Amiodarone Hcl | 92 | 11 |
| Celecoxib | Celecoxib | 92 | 17 |
| Hydralazine Hcl | Hydralazine Hcl | 92 | 21 |
| Fluticasone Propionate | Fluticasone Propionate | 90 | 33 |
| Nifedipine Er | Nifedipine | 86 | 22 |
| Spironolactone | Spironolactone | 85 | 20 |
| Citalopram Hbr | Citalopram Hydrobromide | 82 | 18 |
| Nebivolol Hcl | Nebivolol Hcl | 82 | 17 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 81 | 11 |
| Metoclopramide Hcl | Metoclopramide Hcl | 77 | 12 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 75 | 14 |
| Tizanidine Hcl | Tizanidine Hcl | 75 | 20 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 71 | 19 |
| Zolpidem Tartrate | Zolpidem Tartrate | 70 | 15 |
| Clonidine Hcl | Clonidine Hcl | 69 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 68 | 11 |
| Clonazepam | Clonazepam | 68 | 13 |
| Entresto | Sacubitril/Valsartan | 68 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 67 | 33 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 67 | 20 |
| Trulicity | Dulaglutide | 64 | 12 |
| Breo Ellipta | Fluticasone/Vilanterol | 63 | suppressed |
| Lubiprostone | Lubiprostone | 63 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 62 | 11 |
| Torsemide | Torsemide | 62 | 12 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 60 | 12 |
| Ropinirole Hcl | Ropinirole Hcl | 60 | 11 |
| Sevelamer Carbonate | Sevelamer Carbonate | 60 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 59 | suppressed |
| Digoxin | Digoxin | 59 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 59 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 58 | 12 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 58 | 32 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 55 | 13 |
| Famotidine | Famotidine | 55 | 16 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 55 | 28 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 55 | 12 |
| Doxycycline Hyclate | Doxycycline Hyclate | 54 | suppressed |
| Risperidone | Risperidone | 53 | 14 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 50 | 15 |
| Propranolol Hcl | Propranolol Hcl | 50 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 48 | 34 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 48 | suppressed |
| Ketoconazole | Ketoconazole | 46 | 13 |
| Lorazepam | Lorazepam | 46 | 12 |
| Memantine Hcl Er | Memantine Hcl | 46 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 46 | 13 |
| Ventolin Hfa | Albuterol Sulfate | 46 | suppressed |
| Ezetimibe | Ezetimibe | 44 | 14 |
| Farxiga | Dapagliflozin Propanediol | 44 | suppressed |
| Nystatin | Nystatin | 44 | 22 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 42 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 42 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 41 | suppressed |
| Lactulose | Lactulose | 41 | 11 |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 40 | suppressed |
| Bumetanide | Bumetanide | 37 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 36 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 36 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 35 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 35 | 11 |
| Humalog Kwikpen U-100 | Insulin Lispro | 35 | suppressed |
| Minocycline Hcl | Minocycline Hcl | 34 | 21 |
| Solifenacin Succinate | Solifenacin Succinate | 34 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 34 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 33 | suppressed |
| Calcitriol | Calcitriol | 32 | suppressed |
| Methocarbamol | Methocarbamol | 32 | suppressed |
| Ramelteon | Ramelteon | 32 | suppressed |
| Sucralfate | Sucralfate | 32 | suppressed |
| Ranolazine Er | Ranolazine | 31 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 30 | suppressed |
| Atenolol | Atenolol | 29 | suppressed |
| Azithromycin | Azithromycin | 29 | 24 |
| Cephalexin | Cephalexin | 29 | 24 |
| Dicyclomine Hcl | Dicyclomine Hcl | 29 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 29 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 28 | suppressed |
| Carbamazepine | Carbamazepine | 28 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 28 | suppressed |
| Januvia | Sitagliptin Phosphate | 28 | suppressed |
| Letrozole | Letrozole | 28 | suppressed |
| Brilinta | Ticagrelor | 27 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 27 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 26 | suppressed |
| Movantik | Naloxegol Oxalate | 26 | suppressed |
| Novolin R | Insulin Regular, Human | 26 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 26 | suppressed |
| Bicalutamide | Bicalutamide | 25 | suppressed |
| Cefdinir | Cefdinir | 24 | 19 |
| Clonidine | Clonidine | 24 | suppressed |
| Enulose | Lactulose | 24 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 24 | suppressed |
| Gemtesa | Vibegron | 24 | suppressed |
| Glipizide | Glipizide | 24 | suppressed |
| Irbesartan | Irbesartan | 24 | suppressed |
| Lacosamide | Lacosamide | 24 | suppressed |
| Lovastatin | Lovastatin | 24 | suppressed |
| Febuxostat | Febuxostat | 23 | suppressed |
| Methylprednisolone | Methylprednisolone | 23 | 18 |
| Tradjenta | Linagliptin | 23 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 22 | suppressed |
| Bupropion Xl | Bupropion Hcl | 22 | suppressed |
| Fentanyl | Fentanyl | 22 | suppressed |
| Fluconazole | Fluconazole | 22 | 14 |
| Liothyronine Sodium | Liothyronine Sodium | 22 | suppressed |
| Valsartan | Valsartan | 22 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 21 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 21 | suppressed |
| Naproxen | Naproxen | 21 | suppressed |
| Nitroglycerin | Nitroglycerin | 21 | 12 |
| Ondansetron Odt | Ondansetron | 21 | 15 |
| Valacyclovir | Valacyclovir Hcl | 21 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 20 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 19 | 16 |
| Isosorbide Mononitrate | Isosorbide Mononitrate | 19 | suppressed |
| Lidocaine | Lidocaine | 19 | suppressed |
| Synjardy | Empagliflozin/Metformin Hcl | 19 | suppressed |
| Temazepam | Temazepam | 19 | suppressed |
| Xtandi | Enzalutamide | 19 | suppressed |
| Ibuprofen | Ibuprofen | 18 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 18 | suppressed |
| Mirabegron Er | Mirabegron | 18 | suppressed |
| Olanzapine | Olanzapine | 18 | suppressed |
| Phenytoin | Phenytoin | 18 | suppressed |
| Rexulti | Brexpiprazole | 18 | suppressed |
| Soliqua 100-33 | Insulin Glargine/Lixisenatide | 18 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 17 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 17 | suppressed |
| Gvoke Hypopen 1-Pack | Glucagon | 17 | suppressed |
| Rybelsus | Semaglutide | 17 | suppressed |
| Synthroid | Levothyroxine Sodium | 17 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 17 | suppressed |
| Glimepiride | Glimepiride | 16 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 16 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 16 | suppressed |
| Aripiprazole | Aripiprazole | 15 | suppressed |
| Belsomra | Suvorexant | 15 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 15 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 15 | suppressed |
| Tolterodine Tartrate | Tolterodine Tartrate | 15 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 15 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 14 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 14 | suppressed |
| Estradiol | Estradiol | 14 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 14 | suppressed |
| Paxlovid (Eua) | Nirmatrelvir/Ritonavir | 14 | 14 |
| Clindamycin Hcl | Clindamycin Hcl | 13 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 13 | suppressed |
| Drospirenone-Ethinyl Estradiol | Ethinyl Estradiol/Drospirenone | 13 | suppressed |
| Linzess | Linaclotide | 13 | suppressed |
| Novolog Flexpen | Insulin Aspart | 13 | suppressed |
| Pulmozyme | Dornase Alfa | 13 | suppressed |
| Testosterone | Testosterone | 13 | suppressed |
| Amitiza | Lubiprostone | 12 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 12 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 12 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 12 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 12 | 11 |
| Midodrine Hcl | Midodrine Hcl | 12 | suppressed |
| Novolin N | Insulin Nph Human Isophane | 12 | suppressed |
| Prolia | Denosumab | 12 | suppressed |
| Rivastigmine | Rivastigmine | 12 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 12 | suppressed |
| Veltassa | Patiromer Calcium Sorbitex | 12 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 11 | suppressed |
| Carisoprodol | Carisoprodol | 11 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 11 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 11 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 11 | suppressed |
| Gemfibrozil | Gemfibrozil | 11 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 11 | suppressed |
| Levemir Flexpen | Insulin Detemir | 11 | suppressed |
| Nabumetone | Nabumetone | 11 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 11 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 11 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 11 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $183.35 · 8 records | Stryker Corporation | ACTIV.A.C., CAPVAXIVE, ENFLONSIA, GARDASIL 9, Kerendia, LIMFLOW SYSTEM, PREVENA, REXULTI, VAXNEUVANCE | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Rexulti play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Otsuka America Pharmaceutical, Inc.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error